Zenas Biopharma has acquired global rights to develop BTK inhibitor orelabrutinib to treat progressive forms of multiple ...

Scientists have identified an unusual type of brain cell that may play a vital role in progressive multiple sclerosis (MS), ...

Scientists have identified an unusual type of brain cell that may play a vital role in progressive multiple sclerosis (MS), ...

The CAR T-cell therapy equecabtagene autoleucel, or eque-cel, was shown in trial to improve walking ability for five ...

Researchers have identified a rare type of brain cell that may drive the chronic inflammation and neurodegeneration seen in progressive multiple sclerosis (MS).

Vidofludimus calcium currently is being evaluated in relapsing MS in two phase III trials, ENSURE-1 and ENSURE-2. The phase III trials in relapsing MS will further evaluate the effect of vidofludimus ...

Having inactive secondary progressive multiple sclerosis can be confusing. Relapses may stop, but symptoms persist. Get ...

The SPRINT-MS trial was a phase II clinical trial of ibudilast, which is an oral therapy being evaluated for progressive MS. It was a two-year trial evaluated in 255 patients recruited from 28 sites ...

The role of imaging in diagnosing progressive multiple sclerosis (MS) and in assessing prognosis is the subject of a new review. MRI is central in the diagnostic workup of patients suspected of having ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop treatments ...

Doctor reading medical chart Investigators hypothesize siponimod will function as an alternative therapeutic choice to monoclonal antibodies in MS. SEATTLE — Prelaunch, neurologists believed that ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. He's also a ...